Search for: "Janssen Pharmaceutica Inc." Results 41 - 60 of 65
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Sep 2021, 3:31 pm by Dennis Crouch
Janssen Pharmaceutica (appealing institution denials); Apple Inc. v. [read post]
17 Feb 2010, 5:10 am
(Patent Docs) Razadyne (Galantamine) / Strattera (Atomoxetine) – US: Walking the enablement/non-obviousness tightrope: Janssen Pharmaceutica N.V. v. [read post]
21 Jun 2018, 10:33 am by James Innocent
It was first developed by Janssen Pharmaceutica around 1960 and approved for American medical use in 1968 as an injectable anesthetic called Sublimaze. [read post]
2 Feb 2010, 7:28 am by Beck, et al.
N.J. 1981) (label change); Janssen Pharmaceutica, Inc. v. [read post]
10 Jul 2007, 12:49 am
ALM Privacy Policy / Contact Us © 2007 ALM Properties, Inc. [read post]
10 Jun 2009, 10:00 pm
Janssen Pharmaceutica, Inc., 1997 WL 201571, at *9 (N.D. [read post]
25 Nov 2009, 3:00 am
(IP finance)   Australia Trade mark use: We need a more balanced solution – FCA decision in Alcon v Bausch & Lomb (Australian Trade Marks Law Blog) FCA on trade marks as security for costs: Austin, Nichols & Co Inc v Lodestar Anstalt (ipwars) Minister for Innovation decides not to change regulatory regime for books – publishers keep territorial exclusivity (LawFont) (Managing Intellectual Property) Non-English language publications may not be citable art: APO… [read post]
13 May 2010, 12:27 pm by Bexis
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
24 Feb 2011, 1:49 pm by Bexis
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]